¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary carbon dioxide deficit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • saturation deficit
    Æ÷È­ºÎÁ·
  • dioxide
    ÀÌ»êÈ­¹°
  • manganese dioxide
    ÀÌ»êÈ­¸Á°£
  • nitrogen dioxide
    ÀÌ»êÈ­Áú¼Ò
  • sulfur dioxide
    ÀÌ»êȭȲ
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • carbon
    ź¼Ò
  • carbon arc lamp
    ź¼Ò¾ÆÅ©µî
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • carbon monoxide
    ÀÏ»êȭź¼Ò
  • carbon monoxide intoxication
    ÀÏ»êȭź¼ÒÁßµ¶
  • carbon monoxide poisoning
    ÀÏ»êȭź¼ÒÁßµ¶
  • carbon oxysulfide
    »ê¼ÒȲȭº»
  • carbon tetrachloride
    »ç¿°È­Åº¼Ò
  • carbon tetrachloride poisoning
    »ç¿°È­Åº¼ÒÁßµ¶
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary
    ¿ø¹ß-, ÀÏÂ÷-
  • primary polydipsia
    ¿ø¹ß¼º´ÙÀ½Áõ, ÀÏÂ÷Àû´ÙÀ½Áõ, ¿ø¹ß¼º´ÙÀ½´Ù°¥Áõ, ÀÏÂ÷Àû´ÙÀ½´Ù°¥Áõ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ÀÏÂ÷º¹¸·¿°, ¿ø¹ß¹è¸·¿°, ÀÏÂ÷¹è¸·¿°
  • primary stage
    Ãʱâ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sulfur dioxide
    ÀÌ»êȭȲ
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • carbon
    ź¼Ò
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • carbon monoxide
    ÀÏ»êȭź¼Ò
  • carbon oxysulfide
    Ȳȭº»
  • carbon tetrachloride
    »ç¿°È­Åº¼Ò
  • carbon arc lamp
    ź¼Ò¾ÆÅ©µî
  • carbon monoxide intoxication
    ÀÏ»êȭź¼ÒÁßµ¶
  • carbon monoxide poisoning
    ÀÏ»êȭź¼ÒÁßµ¶
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • equivalent carbon
    ´ç·®Åº¼Ò
  • residual carbon
    ÀÜ¿©Åº¼Ò
  • total organic carbon
    ÃÑÀ¯±âź¼Ò
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • primary action
    ÀÏÂ÷±â´É
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • primary adaptation
    ÀÏÂ÷(¼º) ¼øÀÀ(ìéó­àõâ÷ëë).
  • primary adhesion
    ÀÏÂ÷(¼º) À¯Âø(¡­ë¨ó·).
  • primary affect hunger
    ÀÏÂ÷¼º¡¡¾ÖÁ¤°¥¸Á£®
  • primary aldosteronism
    ¿ø¹ß(¼º) ¾Ëµµ½ºÅ×·ÐÁõ(ê«Û¡àõ¡­ñø).
  • primary aldosteronism
    ¿ø¹ß(¼º) ¾Ëµµ½ºÅ×·ÐÁõ(ê«Û¡(àõ)¡­ñø)
  • primary amenorrhea
    ¿ø¹ß¼º ¹«¿ù°æ(ê«Û¡àõÙíêÅÌè), 1Â÷¼º ¹«¿ù°æ
  • primary amenorrhea
    ¿ø¹ß(¼º) ¹«¿ù°æ(ê«Û¡(àõ) ÙíêÅÌè)
  • primary amine
    ÀÏÂ÷¾Æ¹Î.
  • primary amnion
    ÀÏÂ÷¾ç¸·
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbon dioxide narcosis
    ÀÌ»êȭź¼Ò È¥¼ö(ì£ß«ûù÷©áÈûçâ²)
  • carbon dioxide retention
    ź»ê°¡½ºÃàÀû.
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý(ê¡Úæ)(À̵¿,¼ö¼Û)
  • extracorporeal carbon dioxide removal =ECCO2R
    ü¿ÜÀÌ»êȭź¼Ò Á¦°Å¹ý
  • laser, carbon dioxide
    ź»ê°¡½º ÀÌ»êȭź¼Ò·¹ÀÌÀú
  • oxygen carbon dioxide diagram
    »ê¼ÒÀÌ»êȭź¼ÒµµÇ¥(ß«áÈì£ß«ûù÷©áÈÓñøú).
  • partial pressure of carbon dioxide
    ź»ê°¡½ººÐ¾Ð(̬Ë×ÊÙËÓËâ).
  • partial pressure of carbon dioxide
    ź»ê°¡½ººÐ¾Ð(÷©ß«¡­ÝÂäâ).
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇÌ °ú´ÙȰµ¿Àå¾Ö(º´)
  • attention deficit with hyperactivity
    °ú´ÙȰµ¿µ¿¹Ý ÁÖÀǷ°áÇÌ
  • attention-deficit disorder(ADD)
    ÁÖÀǷ°áÇÌÀå¾Ö(º´)
  • base deficit
    ¿°±â°áÇÌ, ¿°±âºÎÁ·(ç¤ÐñÝÕ ðë).
  • base excess/deficit
    ¿°±â°úÀ×/°áÇÌ
  • deficit oxygen
    »ê¼Ò°áÇÌ(Ë×ËÛ˭̰).
  • deficit syndrome
    °áÇÌÁõÈıº(ÌÀù¹ñøý¦ÏØ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] ÀÏÂ÷µÎÁ¤¸Æ
  • Primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð¼¼Ç÷°ü¸Á
  • Primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÏÂ÷Àûº¹ºÎÂø»ó
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary alkalosis
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®Áõ(ñø)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
  • primary deficiency
    ¿ø¹ß¼º °áÇÌ(ê«Û¡àõÌÀù¹)
  • primary derived protein
    ÀÏÂ÷ À¯µµ ´Ü¹éÁú(ìéó­ë¯ÓôÓ±ÛÜòõ)
  • primary filament
    ÀÏÂ÷(ìéó­) Çʶó¸àÆ®
  • primary fluor
    ÀÏÂ÷ Çü±¤Ã¼(ìéó­û«ÎÃô÷)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary ionization
    ÀÏÂ÷(ìéó­) ÀÌ¿ÂÈ­(ûù)
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
  • primary lysosome
    ÀÏÂ÷(ìéó­) ¶óÀ̼ÒÁ»
  • primary messenger
    ÀÏÂ÷ Àü·É(ìéó­îîÖµ)
  • primary metabolite
    ÀÏÂ÷ ´ë»ç¹°Áú(ìéó­ÓÛÞóÚªòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary lobule
    ÀÏÂ÷¼Ò¿±
  • primary ossification center
    ÀÏÂ÷°ñÈ­Áß½É
  • primary ray
    ÀÏÂ÷¼±
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
  • primary tumor
    ¿ù¹ßÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CDT carbohydrate-deficient transferrin; carbon dioxide therapy; Certified Dental Technician; children's ...
CO2 carbon dioxide
ctCO2 carbon dioxide concentration
DCCO2 diffusing capacity for carbon dioxide
DLCO2 carbon dioxide diffusion in the lungs
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SC-CO2 Supercritical carbon dioxide
PCO2 pressure , carbon dioxide pressure
PACO2 pressure of arterial carbon dioxide
primary SS Primary Sjogren's syndrome
NO2 Nitrogen Dioxide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molybdenum dioxide
    ÀÌ»êÈ­ ¸ô¸®ºêµ§
  • silicon dioxide colloidal
    ÄÝ·ÎÀ̵å»ó ÀÌ»êÈ­ ±Ô¼Ò
    ±Ô¼Ò È­ÇÕ¹°ÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¸¸µé¾îÁø ÃÊÇö¹Ì°æÀû ¿¬¹«È­ ½Ç¸®Ä«·Î¼­, Á¤Á¦ Èñ¼®Á¦, ÇöŹȭÁ¦, ³óÁ¶È­Á¦·Î »ç¿ëµÈ´Ù.
  • sulfur dioxide control
    ÀÌ»êÈ­ Ȳ °¡½º ±ÔÁ¦
  • asymmetric carbon atom
    ºñ´ëĪ ź¼Ò ¿øÀÚ
  • asymmetrical carbon atom
    ºñ´ëĪ ź¼Ò ¿øÀÚ
  • carbon
    ź¼Ò
    ºñ±Ý¼Ó 4°¡ ¿ø¼Ò. °ÅÀÇ ¼ø¼öÇÑ ÇüÀ¸·Î´Â ´ÙÀ̾Ƹóµå¿¡ Á¸ÀçÇϰí, ´ë·« ¼ø¼öÇÑ ÇüÀ¸·Î´Â ź, Èæ¿¬, ¹«¿¬Åº¿¡ ÀÖ´Ù. ¿ø¼Ò±âÈ£ C, ¿øÀÚ¹øÈ£ 6, ¿øÀÚ·® 12.011.
  • carbon arc phototherapy
    Ä«º» ¾ÆÅ© ±¤¿ä¹ý
  • carbon are phototherapy
    ź¼Ò ¾ÆÅ© ±¤¼± ¿ä¹ý
  • carbon coating
    ź¼Ò ÇǺ¹ °¡°ø
  • carbon disulfide poisoning
    ÀÌȲȭ ź¼Ò Áßµ¶
    ÀÌȲȭ ź¼Ò¿¡ ³ëÃâµÇ¾î »ý±â´Â Àü½Å ¼è¾à, ºÒ¸é, ½Ã·Â Àå¾Ö¸¦ Ư¡À¸·Î ÇÏ´Â Áßµ¶ Áõ¼¼.
  • carbon monoxide
    ÀÏ»êÈ­ ź¼Ò
    ¹«»ö À¯µ¶¼ºÀÇ ±âü. CO, ź¼Ò ¶Ç´Â À¯±â ¿¬·á¸¦ »ê¼Ò ºÎÁ· »óÅ¿¡¼­ ¿¬¼Ò½ÃŰ¸é ¹ß»ýÇÑ´Ù. Ç÷»ö¼Ò¿Í ºÒ°¡¿ªÀûÀ¸·Î °áÇÕÇÏ¿© Áú½ÄÀ» ÀÏÀ¸Å²´Ù.
  • carbon monoxide poisoning
    ÀÏ»êÈ­ ź¼Ò Áßµ¶
    ÀÏ»êÈ­ ź¼Ò¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Â Áßµ¶Áõ¼¼. ÀÏ»êÈ­ ź¼Ò´Â ź¼Ò¸¦ ÇÔÀ¯ÇÑ À¯±â¹°ÀÌ ºÒ¿ÏÀü ¿¬¼ÒÇÒ ¶§ ¹ß»ýÇÑ´Ù. µû¶ó¼­ Á¦Ã¶, µµ½Ã°¡½º Á¦Á¶, °¡Á¤¿¡¼­ ¹ß»ýÇϸç ÀÚµ¿Â÷ ¹è±â °¡½º¿¡µµ Æ÷ÇԵǾî ÀÖ°í °¡Á¤¿¡¼­ ¿¬·áÀÇ ¿¬¼Ò¿¡ ÀÇÇØ¼­µµ »ý±ä´Ù. ÀÏ»êÈ­ ź¼Ò¸¦ ÈíÀÔÇÏ¸é Æó¿¡¼­ Ç÷¾× ¼ÓÀÇ Çì¸ð±Û·Îºó°ú °áÇÕÇÏ¿© ÀÏ»êÈ­ ź¼Ò Çì¸ð±Û·ÎºóÀ» Çü¼ºÇϰí, ÀÌ ¶§¹®¿¡ Ç÷¾×ÀÇ »ê¼Ò ¿î¹Ý ´É·ÂÀÌ »ó½ÇµÇ¾î ³»ºÎÀûÀÎ Áú½Ä »óÅ¿¡ ºüÁö°Ô µÈ´Ù. ÀÏ»êÈ­ ź¼Ò¿Í Çì¸ð±Û·Îºó°úÀÇ Ä£È­¼ºÀº ±ØÈ÷ °­ÇÏ¿© »ê¼Òº¸´Ù 250¹èÀÇ ¼¼±â·Î °áÇÕÇÑ´Ù. »ç¶÷¿¡ µû¶ó ÀÏ»êÈ­ ź¼Ò¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ´Ù¸£Áö¸¸, °ø±â ¼Ó¿¡ 0.001 %¸¸ µé¾î À־ Áßµ¶À» ÀÏÀ¸Å²´Ù. ¶Ç 0.06 %¿¡¼­´Â 1½Ã°£¸¸ ÈíÀÔÇÏ¸é µÎÅëÀ» ÀÏÀ¸Å°°í 2½Ã°£ÀÌ¸é ½Ç½ÅÇÑ´Ù. ¶Ç 0.1 %ÀÇ °æ¿ì´Â 1½Ã°£ À̳»¿¡ ½Ç½ÅÇϰí 4½Ã°£ÀÌ¸é »ç¸ÁÇÑ´Ù. Áßµ¶ Áõ¼¼´Â Á¶Á÷ÀÇ ¹«»ê¼ÒÁõ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, ±Þ¼º Áßµ¶Àº ±Þ°ÝÈ÷ »ç¸ÁÇÏ´Â ¼öµµ ÀÖÁö¸¸, ´ë°³´Â óÀ½¿¡ µÎÅë, Çö±âÁõ, À̸í, ±¸¿ªÁú, ±¸Åä µîÀÌ ÀÖ°í, »çÁöÀÇ ¿îµ¿ÀÌ ºÒ°¡´ÉÇÏ°Ô µÇ¸ç, ´Ù¼ÒÀÇ ÀǽÄÀÌ ³²¾Æ À־ ±×´ë·Î Á×À½¿¡ À̸£°Ô µÈ´Ù. Ÿ°¢ÀûÀ¸·Î´Â ¾È¸é¿¡ È«Á¶¸¦ ¶ì°í Àü½Å¿¡ ¹«´Ì ¸ð¾çÀÇ ¹ßÀûÀÌ ³ªÅ¸³ª¸ç, È£ÈíÀÌ °¡´Ã°í ºÒ±ÔÄ¢ÇÏ°Ô µÈ´Ù. ÄÚ¸¦ °ñ°í ü¿ÂÀÌ ³»·Á°¡°í Àü½ÅÀÇ ±ÙÀ° ÀÌ¿Ï µîÀÌ º¸À̸ç, È£Èí°ï¶õÀÇ Áõ¼¼°¡ º¸ÀÌÁö ¾Ê´Â Áß¿¡ È£ÈíÀÌ Á¤ÁöÇÏ°Ô µÈ´Ù. ´ÙÇàÈ÷ »ý¸íÀ» °ÇÁø °æ¿ì¿¡µµ ÈÄÀ¯ÁõÀÌ ³²´Âµ¥, ±× Áõ¼¼·Î´Â µÎÅë, Çö±âÁõ, ±Ù¹«·ÂÁõ, ºÒ¸é, ¿À½ÉÀ» ºñ·ÔÇÏ¿© ±â¾ï·Â, ½Ã·Â, û·Â, ¾ð¾îÀå¾Ö, ºÒ¼öÀÇ ¿îµ¿, ¸¶ºñ µîÀÌ ³ªÅ¸³­´Ù. Ä¡·á·Î¼­´Â µÉ¼ö·Ï »¡¸® ½Å¼±ÇÑ °ø±â ¼ÓÀ¸·Î ¿Å±â°í, Àΰø È£ÈíÀ̳ª »ê¼Ò ÈíÀÔ µîÀ» Çϰí Àý´ë ¾ÈÁ¤À» ½ÃŲ´Ù. »ê¼Ò ÈíÀÔ¿¡´Â 95 %ÀÇ »ê¼Ò¿¡ 5 %ÀÇ Åº»ê °¡½º¸¦ È¥ÇÕÇϸé È£Èí ÁßÃ߸¦ ÀÚ±ØÇϰí, ¶Ç´Â »ê¼º ¹ÝÀÀ¿¡¼­´Â ÀÏ»êÈ­ ź¼Ò°¡ ºÒ¾ÈÁ¤ÇØÁ® ¹èÃâµÇ±â ½¬¿öÁø´Ù. ±×¹Û¿¡ ȣȩ ÀÚ±ØÁ¦¸¦ ÁÖ»çÇϰųª, »çÇ÷ÇÑ ´ÙÀ½ ¼öÇ÷ ¶Ç´Â Æ÷µµ´ç ¾×, ¸µ°Å ¾× µîÀ» ÁÖÀÔÇϰí, ¶Ç °­½ÉÁ¦ µîÀ» Åõ¿©Çϱ⵵ ÇÑ´Ù. ¸¸¼º Áßµ¶Àº ±ØÈ÷ ¹Ì·®ÀÇ ÀÏ»êÈ­ ź¼Ò¸¦ ¹Ýº¹ÇÏ¿© ÈíÀÔÇÑ °á°ú ÀϾ´Â °ÍÀ¸·Î¼­, ±Þ¼º Áßµ¶ÀÇ ÈÄÀ¯Áõ°ú ºñ½ÁÇÑ Áõ¼¼¸¦ ³ªÅ¸³½´Ù. Áï, µÎÅë, ±Çۨ, ±â¾ï·Â °¨Åð, Çö±âÁõ, ºÒ¸éÁõ, ¾ð¾îÀå¾Ö, ºóÇ÷, Ȳ´Þ, ±¸Åä µîÀÇ Áõ¼¼°¡ º¸À̰í, ¶§·Î´Â ±Þ¼º ½É ¼è¾à¿¡ ºüÁ® Á×´Â Àϵµ ÀÖ´Ù.
  • carbon paper
    ±³ÇÕÁö
    ÀÚ¿¬ Ä¡¾Æ³ª ¸ðÇü»ó¿¡¼­ »óÇÏ Ä¡¾Æ »çÀÌ¿¡ ³Ö°í ±³ÇÕ½ÃÄÑ Á¢ÃË °ü°è¸¦ °Ë»çÇÏ´Â ¸ÔÁö¿Í °°Àº °Í. µÎ²²°¡ ¾ã°í, ±¤¹üÀ§ÇÏ°Ô ¹¯Áö ¾Ê´Â °ÍÀϼö·Ï ÁÁ´Ù. Á¤È®ÇÑ ±³ÇÕÀÇ ¼ö¸³°ú ±³ÇÕ °£¼·À» Á¶Á¤ÇÏ´Â µ¥ »ç¿ëµÈ´Ù.
  • one carbon moiety
    ÀÏź¼Ò ¸ðÀÌ¾îÆ¼
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
attention deficit disorder An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
attention deficit disorder with hyperactivity A behaviour disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood.
(12 Dec 1998)
attention deficit hyperactivity disorder <psychiatry> A condition seen in children where there is increased motor activity in association with poor attention span. Often treated with amphetamine medications.
(27 Sep 1997)
base deficit A decrease in the total concentration of blood buffer base, indicative of metabolic acidosis or compensated respiratory alkalosis.
(05 Mar 2000)
pulse deficit The absence of palpable pulse waves in a peripheral artery for one or more heart beats, as is often seen in atrial fibrillation, the number of such missing pulse waves (usually expressed as heart rate minus pulse rate per minute).
(05 Mar 2000)
deficit A lack or deficiency.
(18 Nov 1997)
oxygen deficit The difference between oxygen uptake of the body during early stages of exercise and during a similar duration in a steady state of exercise; sometimes considered as the formation of the oxygen debt.
(05 Mar 2000)
colloidal silicon dioxide A submicroscopic fumed silica prepared by the vapor-phase hydrolysis of a silicon compound; used as a tablet diluent and as a suspending and thickening agent.
(05 Mar 2000)
hydrogen dioxide <chemical> Hydrogen peroxide is produced by vertebrate phagocytes and is used in bacterial killing (the myeloperoxidase halide system).
(05 May 1997)
silicon dioxide <chemical> Silica. Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, quartz, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid.
Chemical name: Silica
(12 Dec 1998)
nitrogen dioxide <chemical> Nitrogen oxide (no2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting oedema several days later may cause death. It is a major atmospheric pollutant that is able to absorb uv light that does not reach the earth's surface.
Pharmacological action: oxidants, photochemical, poisons.
Chemical name: Nitrogen oxide (NO2)
(12 Dec 1998)
sulfur dioxide <chemical> A highly toxic, colourless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.
Pharmacological action: air pollutants, environmental, antioxidants, pharmaceutic aid.
Chemical name: Sulfur dioxide
(12 Dec 1998)
dioxide <chemistry> An oxide containing two atoms of oxygen in each molecule; binoxide.
An oxide containing but one atom or equivalent of oxygen to two of a metal; a suboxide. Carbon dioxide. See Carbonic acid, under Carbonic.
Origin: Pref. Di- + oxide.
Source: Websters Dictionary
(01 Mar 1998)
thorium dioxide <chemical> Thorium oxide (tho2). A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.
Pharmacological action: carcinogens.
Chemical name: Thorium oxide (ThO2)
(12 Dec 1998)
titanium dioxide TiO2;contains not less than 99.0% and not more than 100.5% of TiO2, calculated on the dry basis; used in creams and powders as a protectant against external irritations and solar rays.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbon dating
    ¹æ»ç¼º ź¼Ò ¿¬´ë ÃøÁ¤¹ý
  • carbon diamond
    =CARBONADO
  • carbon fiber
    ź¼Ò ¼¶À¯
  • carbon knock
    (¿£ÁøÀÇ)ºÒ¿ÏÀü ¿¬¼Ò·Î »ý±â´Â ³ëÅ© ¼Ò¸®
  • carbon monoxide
    ÀÏ»êȭź¼Ò
  • carbon paper
    Ä«º»Áö(º¹»ç¿ë)
  • carbon pile
    ź¼Ò ¿øÀÚ·Î
  • carbon process
    (printing)Ä«º»ÀÎÈ­¹ý
  • carbon steel
    ź¼Ò°­
  • carbon tetrachloride
    4¿°È­Åº¼Ò(µå¶óÀÌŬ¸®´× ¾àǰ.¼ÒÈ­Á¦)
  • gas carbon
    °¡½º Ä«º»;°¡½ºÅº(¼®Åº°¡½º Á¦Á¶Áß¿¡ »ý±â´Â)
  • primary
    Áß¿äÇÑ
  • closed primary
    Á¦ÇÑ ¿¹ºñ ¼±°Å(´ç¿ø À¯ÀÚ°ÝÀÚ¸¸ÀÌ ÅõÇ¥ÇÏ´Â Èĺ¸ÀÚ ¼±°Å)
  • dircct primary
    Á÷Á¢ ¿¹¼±
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á